ALBANY, N.Y.--(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2011 fourth quarter and full year financial results on Thursday, July 14, 2011, after the close of the U.S. financial markets.
Scott Solano, AngioDynamics’ interim Chief Executive Officer, and Joseph Gersuk, Executive Vice President and Chief Financial Officer, will host an investment community conference call beginning at 4:30 p.m. Eastern Time on July 14, 2011, to discuss the results and to answer questions.
To participate in the live call by telephone, please dial +1 (877) 941-6009.
Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics’ Web site at http://investors.angiodynamics.com. To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download and install the necessary audio software. The conference call will also be archived on the Web site.
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
Investor Relations Contacts:
EVC Group, Inc.
Doug Sherk, 415-568-4887
Greg Gin, 646-445-4801
EVC Group, Inc.
Chris Gale, 646-201-5431
KEYWORDS: United States North America New York
INDUSTRY KEYWORDS: Surgery Health Biotechnology Hospitals Medical Devices Oncology